Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human Lymphotoxin-alpha/TNF-beta Protein

Catalog No. 211TBB010
Change view
Click to view available options
Quantity:
10 μg
50 μg
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Lyophilized from a 0.2 μm filtered solution in PBS.
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity Formulation
21-1TB-B010 10 μg Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
21-1TB-B050 50 μg Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
21-1TB-B010CF 10 μg Lyophilized from a 0.2 μm filtered solution in PBS.
21-1TB-B050CF 50 μg Lyophilized from a 0.2 μm filtered solution in PBS.
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Catalog No. 21-1TB-B010 Supplier R&D Systems™ Supplier No. 211TBB010
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. Matthews, N. and M.L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 221. The ED50 for this effect is 4-20 pg/mL.

Order Info

The product is shipped at ambient temperature. Upon receipt, store it immediately

Specifications

Accession Number P01374
For Use With (Application) Bioactivity
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Gene ID (Entrez) 4049
Molecular Weight (g/mol) M.W. (Observed): 17-19 kDa, reducing conditions; M.W. (theoretical): 19 kDa
Name Lymphotoxin-alpha/TNF-beta
Preparation Method Reconstitute at 100μg/mL in PBS containing at least 0.1% human or bovine serum albumin.
Quantity 10 μg
Source E. coli-derived human Lymphotoxin-alpha/TNF-beta protein Leu35-Leu205, with an N-terminal Met
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
Endotoxin Concentration <0.01 EU / 1 μg of the protein by the LAL method.
Gene Symbol LTA
Conjugate Unconjugated
Recombinant Recombinant
Reconstitution Reconstitute at 100 μg/mL in PBS containing (at least 0.1% human or bovine serum albumin.)
Form Powder
Purity or Quality Grade >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
Protein Lymphotoxin-alpha/TNF-beta
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.